High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.

BACKGROUND Better understanding of complications and outcomes of adults hospitalized with respiratory syncytial virus (RSV) infection is necessary. METHODS A retrospective cohort study was conducted on all adults (≥ 18 years) admitted to 3 acute care general hospitals in Hong Kong with virologically confirmed RSV infection during 2009-2011 (N = 607). Adults hospitalized for seasonal influenza during the period were used for comparison (n = 547). Both infections were prospectively diagnosed following a standard protocol. Independent reviews of chest radiographs were performed by radiologists. Main outcome measures were all-cause death, respiratory failure requiring ventilatory support, and hospitalization duration. Cox proportional hazards models were used for analyses. RESULTS The mean age of RSV patients was 75 (SD, 16) years; 87% had underlying conditions. Lower respiratory and cardiovascular complications were diagnosed in 71.9% (pneumonia, 42.3%; acute bronchitis, 21.9%; chronic obstructive pulmonary disease/asthma exacerbation, 27.3%) and 14.3% of patients, respectively; 12.5% had bacterial superinfections. Supplemental oxygen and ventilatory support were required in 67.9% and 11.1%, respectively. Crude all-cause mortality was 9.1% and 11.9% within 30 days and 60 days, respectively; mean length of stay of survivors was 12 (SD, 13) days. Advanced age, radiographic pneumonia, requirement for ventilation, bacterial superinfection, and elevated urea level and white blood cell count were independently associated with poorer survival. Systemic corticosteroid use was associated with longer hospitalization and secondary infections. The overall outcomes of survival and length of stay were not significantly different from those in influenza. CONCLUSIONS RSV can cause severe lower respiratory complications in older adults, resulting in respiratory failure, prolonged hospitalization, and high mortality similar to seasonal influenza. Corticosteroids did not seem to improve outcomes. The unmet need for antiviral therapy and vaccination against RSV in adults should be promptly addressed.

[1]  B. Vandermeer,et al.  Glucocorticoids for acute viral bronchiolitis in infants and young children. , 2013, The Cochrane database of systematic reviews.

[2]  Derick R. Peterson,et al.  Viral shedding and immune responses to respiratory syncytial virus infection in older adults. , 2013, The Journal of infectious diseases.

[3]  Prevalence and clinical characteristics of human respiratory syncytial virus in Chinese adults with acute respiratory tract infection† , 2012, Journal of medical virology.

[4]  H. Park,et al.  Viral infection in patients with severe pneumonia requiring intensive care unit admission. , 2012, American journal of respiratory and critical care medicine.

[5]  S. Choi,et al.  Efficacy of Oral Ribavirin in Hematologic Disease Patients with Paramyxovirus Infection: Analytic Strategy Using Propensity Scores , 2012, Antimicrobial Agents and Chemotherapy.

[6]  R. Kuchenbecker,et al.  Optimization of one-step duplex real-time RT-PCR for detection of influenza and respiratory syncytial virus in nasopharyngeal aspirates. , 2012, Journal of virological methods.

[7]  R. Syha,et al.  Human metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults--initial CT findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections. , 2012, European journal of radiology.

[8]  M. Kretzschmar,et al.  Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. , 2012, The Journal of infectious diseases.

[9]  K. Edwards,et al.  Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. , 2012, The Journal of infectious diseases.

[10]  T. Cesario.  Viruses Associated With Pneumonia in Adults , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  E. Walsh,et al.  The Effect of Steroid Use in Hospitalized Adults With Respiratory Syncytial Virus-Related Illness , 2011, Chest.

[12]  E. Picard,et al.  Dexamethasone in community-acquired pneumonia , 2011, The Lancet.

[13]  B. Bharti,et al.  Dexamethasone in community-acquired pneumonia , 2011, The Lancet.

[14]  J. Wedzicha,et al.  Controversies in treatment of chronic obstructive pulmonary disease , 2011, The Lancet.

[15]  E. Walsh,et al.  Respiratory Syncytial Virus Infection in Adults , 2011, Seminars in respiratory and critical care medicine.

[16]  J. V. van Woensel,et al.  Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: A randomized controlled trial* , 2011, Critical care medicine.

[17]  D. Hui,et al.  Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? , 2011, The Journal of infectious diseases.

[18]  John A. Tallarico,et al.  Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) , 2011, Proceedings of the National Academy of Sciences.

[19]  R. Chemaly,et al.  Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. , 2011, Blood.

[20]  J. Sung,et al.  Viral Clearance and Inflammatory Response Patterns in Adults Hospitalized for Pandemic 2009 Influenza A(H1N1) Virus Pneumonia , 2011, Antiviral therapy.

[21]  Kwok-Hung Chan,et al.  Virologically Confirmed Population-based Burden of Hospitalization Caused by Respiratory Syncytial Virus, Adenovirus, and Parainfluenza Viruses in Children in Hong Kong , 2010, The Pediatric infectious disease journal.

[22]  J. Oxford,et al.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus. , 2010, American journal of respiratory and critical care medicine.

[23]  J. Sung,et al.  Outcomes of adults hospitalised with severe influenza , 2010, Thorax.

[24]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[25]  Rob Lambkin-Williams,et al.  A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus , 2010, Proceedings of the National Academy of Sciences.

[26]  W L Nicholson,et al.  Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand , 2010, Epidemiology and Infection.

[27]  William G Lindsley,et al.  Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Derick R. Peterson,et al.  Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. , 2009, The Journal of infectious diseases.

[29]  J. Sung,et al.  Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza , 2009, The Journal of infectious diseases.

[30]  O. Ramilo,et al.  Effect of dexamethasone on respiratory syncytial virus‐induced lung inflammation in children: results of a randomized, placebo controlled clinical trial , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[31]  M. Rovers,et al.  The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial , 2009, BMJ : British Medical Journal.

[32]  J. Peiris,et al.  Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[33]  A. Hoes,et al.  Influenza- and respiratory syncytial virus-associated mortality and hospitalisations , 2007, European Respiratory Journal.

[34]  Derick R. Peterson,et al.  Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? , 2007, The Journal of infectious diseases.

[35]  E. Walsh,et al.  Respiratory Syncytial Virus Infection in Adults , 2000, Clinical Microbiology Reviews.

[36]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[37]  P. Nassos,et al.  Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ Assays for Detection of Respiratory Syncytial Virus , 2004, Journal of Clinical Microbiology.

[38]  E. Walsh,et al.  Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.